Cargando…
Comparison of HER2-Targeted Antibodies for Fluorescence-Guided Surgery in Breast Cancer
BACKGROUND: Although therapeutic advances have led to enhanced survival in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer, detection of residual disease remains challenging. Here, we examine two approved anti-HER2 monoclonal antibodies (mAbs), trastuzumab and pe...
Autores principales: | AghaAmiri, Solmaz, Simien, Jo, Thompson, Alastair M., Voss, Julie, Ghosh, Sukhen C., Hernandez Vargas, Servando, Kim, Sarah, Azhdarinia, Ali, Tran Cao, Hop S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205604/ https://www.ncbi.nlm.nih.gov/pubmed/34194285 http://dx.doi.org/10.1155/2021/5540569 |
Ejemplares similares
-
Receptor-Targeted Fluorescence-Guided Surgery With Low Molecular Weight Agents
por: Hernandez Vargas, Servando, et al.
Publicado: (2021) -
Development of a drug–device combination for fluorescence-guided surgery in neuroendocrine tumors
por: Hernandez Vargas, Servando, et al.
Publicado: (2020) -
Targeted Dual-Modal PET/SPECT-NIR Imaging: From Building Blocks and Construction Strategies to Applications
por: Usama, Syed Muhammad, et al.
Publicado: (2022) -
High-Contrast
Detection of Somatostatin Receptor Subtype-2
for Fluorescence-Guided Surgery
por: Hernandez Vargas, Servando, et al.
Publicado: (2022) -
Combined multiphoton microscopy and somatostatin receptor type 2 imaging of pancreatic neuroendocrine tumors
por: Daigle, Noelle, et al.
Publicado: (2023)